Pediatric Drug Development &amp; Therapeutics in October TIRS

Fierce Females in the Life Science Space

While human infections of the virus are rare, a strain recently appeared in dairy cows before infecting a human in Texas.

March 29th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Gen-Z Influence on Pharma M&A

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

March 14th 2024

Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Lessons Learned on the Art and Science of Product Commercialization

Rahman discusses the new opportunities that digital twins present to researchers.

Chris Martin, Chief Commercial Officer, Verona Pharma.

Texas Biomed Developing Potential Bird Flu Vaccine

Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.

Related Content

Fierce Females in the Life Science Space

While human infections of the virus are rare, a strain recently appeared in dairy cows before infecting a human in Texas.

March 29th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Gen-Z Influence on Pharma M&A

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

March 14th 2024

Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Lessons Learned on the Art and Science of Product Commercialization

Rahman discusses the new opportunities that digital twins present to researchers.